Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers

Journal of Surgical Oncology

Volumn 95, Issue 1, 2007, Pages 51-54

  Hoffmann, A C ^a   Warnecke Eberz, U ^a   Luebke, T ^a   Prenzel, K ^a   Metzger, R ^a   Heitmann, M ^a   Neiss, S ^a   Vallbohmer, D ^a   Hoelscher, A H ^a   Schneider, P M ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Free tumor cells; Micrometastases; RNA; Tumor markers

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; SURVIVIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MICROMETASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33846278703     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20630     Document Type: Article

References (20)

1. Ghossein RA, Bhattacharya S: Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur J Cancer 2000;36:1681-1694.
2. Nakanishi H, Kodera Y, Tatematsu M: Molecular method to quantitatively detect micrometastases and its clinical significance in gastrointestinal malignancies. Adv Clin Chem 2004;38:87-110.
3. Bustin SA, Gyselman VG, Williams NS, et al.: Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999;79:1813-1820.
4. Ikeguchi M, Ohro S, Maeda Y, et al.: Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med 2003;11:217-221.
5. Lin JC, Chen KY, Wang WY, et al.: PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: Effect of enzyme and sampling. Head Neck 2002;24:591-596.
6. Huang P, Wang J, Guo Y, et al.: Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 2003;129:192-198.
7. Kao RH, Huang LC: High false-positive rate of cytokeratin-19 in detecting circulating tumor cells for nasopharyngeal carcinoma. Chang Gung Med J 2002;25:238-244.
8. Ho SB, Hyslop A, Albrecht R, et al.: Quantification of colorectal cancer micro metastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen. Clin Cancer Res 2004;10:5777-5784.
9. Schuster R, Max N, Mann B, et al.: Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 2004;108:219-227.
10. Vogel I, Kalthoff H: Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001;439:109-117.
11. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
12. Reed JC: The Survivin saga goes in vivo. J Clin Invest 2001;108:965-969.
13. Sommer KW, Schamberger CJ, Schmidt GE, et al.: Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 2003;22:4266-4280.
14. Warnecke-Eberz U, Hokita S, Xi H, et al.: Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Oncol Rep 2005;13:1241-1246.
15. Warnecke-Eberz U, Metzger R, Miyazono F, et al.: High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clin Cancer Res 2004;10:3794-3799.
16. Sharp JD, Hausladen DA, Maher MG, et al.: Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Front Biosci 2001;7:e36-e41.
17. Nemoto T, Kitagawa M, Hasegawa M, et al.: Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 2004;76:253-259.
18. Endo T, Abe S, Seidlar HB, et al.: Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol Immunother 2004;53:770-776.
19. Gradilone A, Gazzaniga P, Silvestri I, et al.: Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: Correlation with clinical stage of disease. Oncol Rep 2003;10:217-222.
20. Weitz J, Kienle P, Magener A, et al.: Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 1999;5:1830-1836.